--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


Growth stocks are harder to value than those with significant yield, but they can offer some of the best opportunities.  This section is for profitable companies which have a chance outgrowing the overall economy and thus rising faster than the market.

It should be noted that the reason for there being more public examples in this section than in Yield is because of the naturally greater rate of turnover.  The majority of my analysis and funds are generally allocated to high-yield value investments which offer growth in addition to income.

Updates:
?3 Ebix 4Q20 report and IPO scheduling12:30 19-Apr-21
?2 gas, macro and new pick09:25 29-Mar-21
+3 Ebix 10-K schedule and macro note09:19 09-Mar-21
-5 Ebix auditor resigns17:48 24-Feb-21
+3 Ebix bus automation and Energy Recovery water treatment contracts09:25 03-Feb-21
?3 AMSC 3Q20 schedule, Indian budget, and more19:29 01-Feb-21
?4 Google Fitbit purchase complete, 4Q20 schedule, more09:37 14-Jan-21
-3 ACCC rejects Google concessions for Fitbit and more11:37 22-Dec-20
+3 Ebix and Prudential in India10:54 15-Dec-20
+2 Hygo case dismissed and Ebix accolades09:32 10-Dec-20
+2 Tina vs Eve: thoughts on inequality00:46 07-Dec-20
?3 new summaries and other administrative notes09:26 30-Nov-20
?2 Lumen, Virtu and other news19:15 23-Nov-20
+3 Ebix 3Q20 results12:01 09-Nov-20
?4 Ebix 3Q20 schedule and AMSC orders09:33 03-Nov-20
?2 Orbital, BGC, Vodafone and other news from India11:52 25-Sep-20
-2 Xebec stock incentives and value updates09:57 21-Sep-20
+2 post-pandemic value thoughts14:51 02-Sep-20
+2 Resonant switches to KPMG and new Fitbit watches14:14 25-Aug-20
?3 Fitbit subscriptions and Resonant dilution09:45 18-Aug-20
+3 Ebix 2Q20 results14:57 07-Aug-20
?2 EMAN short squeeze, MACom products and MX OMIBs19:31 05-Aug-20
-3 full E.U. antitrust probe for Google+Fitbit?11:20 04-Aug-20
?4 Ebix 2Q20 schedule plus more Virtu and market thoughts10:28 03-Aug-20
-2 eMagin defense contract, Nokia schedule and more11:09 27-Jul-20
-2 ABB 2Q20 estimates and troubling thoughts09:16 20-Jul-20
?2 BGC 2Q20 schedule and more on India08:39 17-Jul-20
?2 Covanta & Clearway 2Q20 schedules and much more08:27 15-Jul-20
?3 Fitbit and other regulatory notes13:11 19-Jun-20
?2 Nokia, the pandemic and market pricing08:51 16-Jun-20
+2 Clearway near, BGC & Covanta far from the finish line, Fed could move it13:23 11-Jun-20
?3 Fitbit & macro update13:05 04-Jun-20
?3 Ebix, Yatra, Schlumberger and the virus09:57 21-May-20
?3 Ebix 1Q20 results13:16 11-May-20
?3 Ebix 1Q20 schedule and India health notes15:51 06-May-20
?2 Vodafone 4Q20 schedule, OLED & new normal implications06:19 04-May-20
?4 Fitbit & Google 1Q20 schedules07:45 27-Apr-20
?2 market calendar and minor news09:42 15-Apr-20
?4 new Ebix CFO and debt profile20:40 08-Apr-20
+3 ADP, Fitbit Charge, and more09:06 02-Apr-20
-4 Senate deal, rebate rates, India lockdown, Schlumberger cutback09:14 25-Mar-20
+3 OMIBs from the Ebix C-Suite15:26 13-Mar-20
+3 Sanders, Biden and Fitbit12:30 11-Mar-20
?3 Super Tuesday and Fitbit arbitrage calendar16:39 03-Mar-20
?3 Ebix 4Q19 results01:28 03-Mar-20
?3 Fitbit 4Q19 results and more16:17 20-Feb-20
?4 Ebix 4Q19 schedule and reality shifts20:04 12-Feb-20
?3 Fitbit 4Q19 schedule and confirmations18:19 11-Feb-20
+3 EbixCash partners with MoneyGram and much more09:39 13-Jan-20
-3 Fitbit named in broad patent investigation15:00 11-Jan-20
<<  ◀ Newer
Older ▶  >>